Literature DB >> 23642863

Selected emerging diseases of amphibia.

La'Toya V Latney1, Eric Klaphake.   

Abstract

This review summarizes the most recent updates on emerging infectious diseases of amphibia. A brief summary of Batrachochytrium dendrobatidis history, epidemiology, pathogenesis, life cycle, diagnosis, treatment, and biosecurity is provided. Ambystoma tigrinum virus, common midwife toad virus, frog virus 3, Rana grylio virus, Rana catesbeiana ranavirus, Mahaffey Road virus, Rana esculenta virus, Bohle iridovirus, and tiger frog virus ranaviruses are extensively reviewed. Emerging bacterial pathogens are discussed, including Flavobacter sp, Aeromonas sp, Citrobacter freundii, Chlamydophila sp, Mycobacterium liflandii, Elizabethkingia meningoseptica, and Ochrobactrum anthropi. Rhabdias sp, Ribeiroia sp, and Spirometra erinacei are among several of the parasitic infections overviewed in this article.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23642863     DOI: 10.1016/j.cvex.2013.01.005

Source DB:  PubMed          Journal:  Vet Clin North Am Exot Anim Pract        ISSN: 1094-9194


  3 in total

1.  The effect of captivity on the skin microbial symbionts in three Atelopus species from the lowlands of Colombia and Ecuador.

Authors:  Sandra V Flechas; Ailin Blasco-Zúñiga; Andrés Merino-Viteri; Valeria Ramírez-Castañeda; Miryan Rivera; Adolfo Amézquita
Journal:  PeerJ       Date:  2017-07-31       Impact factor: 2.984

2.  The mental health crises of the families of COVID-19 victims: a qualitative study.

Authors:  Fateme Mohammadi; Khodayar Oshvandi; Farshid Shamsaei; Fateme Cheraghi; Masoud Khodaveisi; Mostafa Bijani
Journal:  BMC Fam Pract       Date:  2021-05-15       Impact factor: 2.497

3.  Cultivable Skin Mycobiota of Healthy and Diseased Blind Cave Salamander (Proteus anguinus).

Authors:  Polona Zalar; Ana Gubenšek; Cene Gostincar; Rok Kostanjšek; Lilijana Bizjak-Mali; Nina Gunde-Cimerman
Journal:  Front Microbiol       Date:  2022-07-14       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.